Optimisation of immunosuppressive therapy using pharmacokinetic principles

Area of Science:

• Pharmacology
• Immunology
• Transplantation

Background:

• Immunosuppressive therapy is crucial for preventing organ transplant rejection and managing autoimmune diseases.
• Prednisone and cyclosporine are key immunosuppressants requiring personalized dosage adjustments.
• Significant inter- and intraindividual variability exists in the pharmacokinetics of these drugs.

Purpose of the Study:

• To review the challenges and strategies for individualizing prednisone and cyclosporine dosage.
• To highlight the pharmacokinetic variability influencing immunosuppressive therapy effectiveness.
• To compare the approaches for optimizing prednisone and cyclosporine dosing.

Main Methods:

• Literature review of pharmacokinetic studies on prednisone and cyclosporine.
• Analysis of factors contributing to inter- and intraindividual variability.
• Discussion of methods for dosage individualization and monitoring.

Main Results:

• Prednisone pharmacokinetics allow for dosage individualization through identified variability sources or single concentration measurements.
• Cyclosporine pharmacokinetics present significant variability, complicating initial safe and effective dosing.
• Establishing optimal cyclosporine dosing requires initial test doses and ongoing pharmacokinetic monitoring.

Conclusions:

• Individualized dosing is essential for prednisone and cyclosporine in immunosuppressive therapy.
• Prednisone dosage can be guided by pharmacokinetic parameters and single concentration measurements.
• Cyclosporine therapy demands intensive pharmacokinetic monitoring for safe and effective immunosuppression due to its narrow therapeutic range and high variability.